Lv1
28 积分 2024-09-14 加入
XPO1 drives resistance to eprenetapopt and azacitidine and can be targeted in TP53 -mutated myeloid malignancies
1个月前
已完结
Molecular characterization of mutant TP53 acute myeloid leukemia and high-risk myelodysplastic syndrome
1个月前
已完结
Managing the unmanageable: evidence-driven approaches to real-world patient prototypes of TP53-mutant myelodysplastic neoplasms and acute myeloid leukemia
1个月前
已完结
Interleukin‐21 Receptor Blockade Inhibits Secondary Humoral Responses and Halts the Progression of Preestablished Disease in the (NZB × NZW)F1 Systemic Lupus Erythematosus Model
1个月前
已完结
IL-21 Has a Pathogenic Role in a Lupus-Prone Mouse Model and Its Blockade with IL-21R.Fc Reduces Disease Progression
1个月前
已完结
Local antibody feedback enforces a checkpoint on affinity maturation in the germinal center and promotes epitope spreading
6个月前
已完结
Impact of TP53 Mutation on Outcome after Allogeneic Stem Cell Transplantation for Patients with MDS/AML Not in Complete Remission
6个月前
已完结
Acute Myeloid Leukemia With Myeloid Sarcoma and Eosinophilia: Prolonged Remission and Molecular Response to Imatinib
7个月前
已完结
Successful Treatment of Relapsed and Refractory Extramedullary Acute Promyelocytic Leukemia With Tamibarotene
7个月前
已完结
The impact of TP53 mutations and TP53 deletions on survival varies between AML, ALL, MDS and CLL: an analysis of 3307 cases
7个月前
已完结
皖公网安备34019202002308
